感覚情報処理機能障害に対するガランタミンの有効性とそのメカニズム

書誌事項

タイトル別名
  • Beneficial Effect of Galantamine on Sensory Information-processing Deficits
  • カンカク ジョウホウ ショリ キノウ ショウガイ ニ タイスル ガランタミン ノ ユウコウセイ ト ソノ メカニズム

この論文をさがす

抄録

  Clinical studies show that galantamine, a weak acetylcholine (ACh) esterase inhibitor and allosteric potentiator of nicotinic ACh receptors (nAChRs), improves negative and cognitive symptoms in schizophrenia, while donepezil, a potent ACh esterase inhibitor, does not. We have recently found that galantamine, but not donepezil, reversed isolation rearing-induced deficits of prepulse inhibition (PPI), sensory information-processing deficits, in mice. In addition, we unexpectedly found that the galantamine-induced improvements in PPI deficits were prevented by the muscarinic ACh receptor (mAChR) antagonists scopolamine and telenzepine (preferential for M1 subtype), but not by the nAChR antagonists. Galantamine, like donepezil, increased extracellular ACh levels in the prefrontal cortex. However, donepezil, unlike galantamine, inhibited M1-mAChR-mediated Ca2+ signal in human neuroblastoma SH-SY5Y. These results suggest that galantamine improves isolation rearing-induced PPI deficits via an activation of mAChRs and the difference in the effect on the PPI deficits between galantamine and donepezil is due to that in their action on M1-mAChRs. The possible mechanisms for the beneficial effect of galantamine are discussed in a model of isolation rearing-induced PPI deficits.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 130 (10), 1305-1310, 2010-10-01

    公益社団法人 日本薬学会

参考文献 (22)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ